According to Xenon Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -2,42 โฌ. In 2022 the company made an earnings per share (EPS) of -1,98 โฌ a decrease over its 2021 EPS that were of -1,72 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -2,35 โฌ | 18.79% |
2022 | -1,98 โฌ | 15.25% |
2021 | -1,72 โฌ | 117.22% |
2020 | -0,79 โฌ | -46.74% |
2019 | -1,48 โฌ | -3.16% |
2018 | -1,53 โฌ | -7.6% |
2017 | -1,66 โฌ | 15.54% |
2016 | -1,44 โฌ | 34.55% |
2015 | -1,07 โฌ | -218.38% |
2014 | 0,90 โฌ |